ADVOCACY FOR IMPACT

Serial Number 88126473
Registration 6603392
700

Registration Progress

Application Filed
Sep 21, 2018
Under Examination
Apr 23, 2019
Approved for Publication
Feb 26, 2019
Published for Opposition
Feb 26, 2019
Registered
Dec 28, 2021

Basic Information

Serial Number
88126473
Registration Number
6603392
Filing Date
September 21, 2018
Registration Date
December 28, 2021
Published for Opposition
February 26, 2019
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 28, 2021
Registration
Registered
Classes
036

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
675 West Kendall Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Deadline
902 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-12-28)
Due Date
December 28, 2027
Grace Period Ends
June 28, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

44 events
Date Code Type Description
Mar 30, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 30, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 30, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 28, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 20, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 19, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 30, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 29, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 29, 2021 EX5G S SOU EXTENSION 5 GRANTED
Oct 29, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Oct 22, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 22, 2021 EXT5 S SOU EXTENSION 5 FILED
Oct 22, 2021 IUAF S USE AMENDMENT FILED
Oct 13, 2021 EISU I TEAS STATEMENT OF USE RECEIVED
Apr 24, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 22, 2021 EXT4 S SOU EXTENSION 4 FILED
Apr 22, 2021 EX4G S SOU EXTENSION 4 GRANTED
Oct 27, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 23, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 23, 2020 EXT3 S SOU EXTENSION 3 FILED
Oct 23, 2020 EX3G S SOU EXTENSION 3 GRANTED
Apr 25, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 23, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 23, 2020 EXT2 S SOU EXTENSION 2 FILED
Apr 23, 2020 EX2G S SOU EXTENSION 2 GRANTED
Oct 25, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 23, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 23, 2019 EXT1 S SOU EXTENSION 1 FILED
Oct 23, 2019 EX1G S SOU EXTENSION 1 GRANTED
Apr 23, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 26, 2019 PUBO A PUBLISHED FOR OPPOSITION
Feb 26, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 6, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2019 ALIE A ASSIGNED TO LIE
Jan 24, 2019 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 9, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jan 9, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED
Jan 9, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 9, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED
Jan 9, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2019 DOCK D ASSIGNED TO EXAMINER
Sep 27, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 25, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 036
Providing grants to patient advocacy groups in support of projects that will have an effect on rare diseases; conducting a competitive grants program, namely, providing grants for patient advocacy groups; charitable services, namely, granting funds to support projects directed to rare diseases
First Use Anywhere: Oct 24, 2018
First Use in Commerce: Oct 24, 2018

Classification

International Classes
036